A worldwide survey on the use of animal‐derived materials and reagents in scientific experimentation
Authors:
Open Access
- 18 July 2022
- journal article
- research article
- Published by Wiley in Engineering in Life Sciences
- Vol. 22 (9) , 564-583
Abstract
The use of cell and tissue‐based methods in basic, applied and regulatory science has been increasing exponentially. Animal‐derived components, including serum, coating materials, growth factors and antibodies are routinely used in cell/tissue cultures and in general laboratory practices. In addition to ethical issues, the use and production of animal‐derived materials and reagents raises many scientific concerns, generally associated with presence of undefined components and batch‐to‐batch variability, which may compromise experimental reproducibility. On the other hand, non‐animal materials and reagents, such as human cells, alternatives to animal sera or non‐animal recombinant antibodies, are becoming increasingly available, and their use is encouraged by the EU Directive 2010/63 and the Guidance Document on Good In vitro Method Practices (GIVIMP), published by the Organization for Economic Cooperation and Development (OECD). In an effort to map the current state of use of animal‐derived reagents across different sectors and to identify the obstacles possibly hampering the implementation of non‐animal derived alternatives, a global online survey addressed to scientists working on in vivo, in vitro, in silico methods, in academia as well as pharmaceutical or cosmetic companies, was conducted with the goal to understand: 1) the most commonly used animal‐derived materials and reagents, 2) the main issues associated with the production and use of animal‐derived materials and reagents, 3) the current level of knowledge on available non‐animal alternative materials and reagents, and 4) what educational and information sources could be most useful or impactful to disseminate knowledge on non‐animal alternatives. This paper provides an overview of the survey replies and discusses possible proposals to increase awareness, acceptance and use of non‐animal ingredients.Keywords
This publication has 33 references indexed in Scilit:
- TrypZean™: An Animal-Free Alternative to Bovine Trypsin2014
- Strategic Focus on 3R Principles Reveals Major Reductions in the Use of Animals in Pharmaceutical Toxicity TestingPLOS ONE, 2014
- Detection of contaminants in cell cultures, sera and trypsinBiologicals, 2013
- Optimization of chemically defined cell culture media – Replacing fetal bovine serum in mammalian in vitro methodsToxicology in Vitro, 2010
- Evolution of Animal-Welfare Education for Veterinary StudentsJournal of Veterinary Medical Education, 2010
- Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).2009
- Recombinant collagen for animal product-free dextran microcarriersIn Vitro Cellular & Developmental Biology - Animal, 2008
- Understanding Animal Sera: Considerations for Use in the Production of Biological Therapeutics2007
- The Use of Fetal Bovine Serum: Ethical or Scientific Problem?Alternatives to Laboratory Animals, 2002
- Microorganisms and their Relation to FeverEpidemiology and Infection, 1912